Canada markets closed
  • S&P/TSX

    19,228.03
    -0.87 (-0.00%)
     
  • S&P 500

    4,128.80
    +31.63 (+0.77%)
     
  • DOW

    33,800.60
    +297.00 (+0.89%)
     
  • CAD/USD

    0.7985
    +0.0024 (+0.30%)
     
  • CRUDE OIL

    59.34
    -0.26 (-0.44%)
     
  • BTC-CAD

    75,239.57
    -587.22 (-0.77%)
     
  • CMC Crypto 200

    1,235.89
    +8.35 (+0.68%)
     
  • GOLD FUTURES

    1,744.10
    -14.10 (-0.80%)
     
  • RUSSELL 2000

    2,243.47
    +0.87 (+0.04%)
     
  • 10-Yr Bond

    1.6660
    +0.0340 (+2.08%)
     
  • NASDAQ

    13,900.19
    +70.89 (+0.51%)
     
  • VOLATILITY

    16.69
    -0.26 (-1.53%)
     
  • FTSE

    6,915.75
    -26.47 (-0.38%)
     
  • NIKKEI 225

    29,768.06
    +59.06 (+0.20%)
     
  • CAD/EUR

    0.6703
    +0.0026 (+0.39%)
     

Evogene: Q4 Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

REHOVOT, Israel (AP) _ Evogene Ltd. (EVGN) on Wednesday reported a loss of $8.1 million in its fourth quarter.

The Rehovot, Israel-based company said it had a loss of 25 cents per share.

The agricultural company posted revenue of $351,000 in the period.

For the year, the company reported that its loss widened to $23.4 million, or 83 cents per share. Revenue was reported as $1 million.

Evogene shares have risen 26% since the beginning of the year. The stock has more than quadrupled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EVGN at https://www.zacks.com/ap/EVGN